Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $10.88 in the prior trading day, Upstream Bio Inc (NASDAQ: UPB) closed at $11.00, up 1.10%. In other words, the price has increased by $1.10 from its previous closing price. On the day, 0.16 million shares were traded. UPB stock price reached its highest trading level at $11.325 during the session, while it also had its lowest trading level at $10.41.
Ratios:
Our goal is to gain a better understanding of UPB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.90 and its Current Ratio is at 20.90. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On November 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $75.Piper Sandler initiated its Overweight rating on November 05, 2024, with a $75 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 15 ’24 when Chimovits Erez bought 825,000 shares for $17.00 per share. The transaction valued at 14,025,000 led to the insider holds 4,554,873 shares of the business.
ORBIMED ADVISORS LLC bought 825,000 shares of UPB for $14,025,000 on Oct 15 ’24. The Director now owns 4,554,873 shares after completing the transaction at $17.00 per share. On Oct 15 ’24, another insider, AI Upstream LLC, who serves as the 10% Owner of the company, bought 1,175,000 shares for $17.00 each. As a result, the insider paid 19,975,000 and bolstered with 1,175,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UPB now has a Market Capitalization of 589562624 and an Enterprise Value of 751718592. Its current Enterprise Value per Revenue stands at 340.607 whereas that against EBITDA is -11.438.
Stock Price History:
Over the past 52 weeks, UPB has reached a high of $29.46, while it has fallen to a 52-week low of $10.36. The 50-Day Moving Average of the stock is -44.33%, while the 200-Day Moving Average is calculated to be -47.53%.
Shares Statistics:
The stock has traded on average 330.48K shares per day over the past 3-months and 260570 shares per day over the last 10 days, according to various share statistics. A total of 53.60M shares are outstanding, with a floating share count of 15.86M. Insiders hold about 70.41% of the company’s shares, while institutions hold 8.03% stake in the company. Shares short for UPB as of 1735603200 were 2302003 with a Short Ratio of 6.97, compared to 1732838400 on 1205876.
Earnings Estimates
Currently, 4 analysts are dedicated to thoroughly evaluating and rating the performance of Upstream Bio Inc (UPB) in the stock market.The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.4 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$2.7 and -$5.45 for the fiscal current year, implying an average EPS of -$4.3. EPS for the following year is -$2.31, with 4.0 analysts recommending between -$2.09 and -$2.68.
